How is the Hereditary Angioedema Therapeutics Market Poised for Growth: Trends and Opportunities Through 2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Predicted Annual Growth Rate of the Hereditary Angioedema Therapeutics Market Over the Coming Decade?
The market for therapeutics in hereditary angioedema has seen a swift expansion in the recent past. The market is projected to rise from $6.68 billion in 2024 to $7.84 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 17.3%. The growth experienced in the historic timeframe can be traced back to factors such as increased awareness and diagnosis, widened access to treatments, initiatives in research and development, patient advocacy and education, alongside regulatory authorizations.
The market for hereditary angioedema therapeutics is predicted to experience swift expansion in the coming years, hitting a size of “$16.11 billion in 2029 with an annual compound growth rate (CAGR) of 19.7%. This growth during the forecast period can be tied to the progress in targeted therapies, the broadening of the worldwide market, development of gene therapy, trends in personalized medicine, and collaborations in research and therapies. Some major trends expected during the forecast period include initiatives for global access, research on health economic outcomes, strategies for early intervention, and therapeutics for pediatric HAE.
What Combination of Drivers Is Leading to Accelerated Growth in the hereditary angioedema therapeutics Market?
The increasing incidence of hereditary angioedema is predicted to lead the hereditary angioedema market towards progression. Hereditary angioedema (HAE), a rare genetic ailment, is marked by consistent episodes of intense swelling in the skin and mucosal areas. This swelling results from excessive accumulation of fluid (EDEMA) and it could manifest anywhere in the body, including hands, feet, face, intestines, and airways. As reported by Rare Disease Advisor, an online resource company providing services to global health care professionals, in June 2022, hereditary angioedema affects 1 out of every 50,000 individuals, with prevalence estimates ranging from 1:10,000 to 1:150,000. In the US, HAE episodes lead to 15,000 to 30,000 ER visits annually. While 5.8% of HAE cases were diagnosed within 0 to 6 months, another 5.8% took over 10 years for diagnosis. Hence, the rise in hereditary angioedema cases contributes to the growth of the hereditary angioedema market.
Explore Comprehensive Insights Into The Global Hereditary Angioedema Therapeutics Market With A Free Sample Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10810&type=smp
What Are the Major Players Making an Impact in the Hereditary Angioedema Therapeutics Market’s Growth?
Major companies operating in the hereditary angioedema therapeutics market include:
• Sanofi S.A._x000D_
• Pharming Healthcare Inc._x000D_
• Attune Pharmaceuticals Inc._x000D_
• Adverum Biotechnologies Inc._x000D_
• Arrowhead Pharmaceuticals Inc._x000D_
Which Upcoming Trends Are Set to Influence the Hereditary Angioedema Therapeutics Market’s Path Forward?
Secure Your Global Hereditary Angioedema Therapeutics Market Report Now for Fast and Efficient Delivery!
Which Key Segments Define the Structure of the Hereditary Angioedema Therapeutics Market and Their Growth Potential?
The hereditary angioedema therapeutics market covered in this report is segmented –
1) By Drug Class: C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Other Drug Classes
2) By Route of Administration: Intravenous, Subcutaneous, Oral
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
4) By Application: Prophylaxis, On-demand
Subsegments:
1) By C1 Esterase Inhibitor: Plasma-Derived, Recombinant
2) By Selective Bradykinin B2 Receptor Antagonist: Icatibant
3) By Kallikrein Inhibitor: Ecallantide, Lanadelumab
4) By Other Drug Classes: Emerging Therapies
What Regions Are Steering Growth in the Hereditary Angioedema Therapeutics Sector?
North America was the largest region in the global hereditary angioedema therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary angioedema therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
How Is the Hereditary Angioedema Therapeutics Market Classified and Defined in Market Analysis?
Hereditary angioedema (HAE) therapeutics refers to therapy for an autosomal dominant condition brought on by a deficiency in or malfunction of the C1-inhibitor protein. Hereditary angioedema symptoms include angioedema-related upper airway, cutaneous, and, or gastrointestinal complaints.
Browse Through More Similar Reports By The Business Research Company:
Online Therapy Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/online-therapy-services-global-market-report
Vitamin D Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/vitamin-d-therapy-global-market-report
Targeted Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/targeted-therapy-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
